Mark T. Eginton
Papers
2
Total Citations
40
H-Index
2
About
Mark T. Eginton is a vascular researcher whose work has illuminated the damaging effects of cigarette smoke on arterial health and, crucially, the potential for reversal. His research centers on endothelial dysfunction—a key early marker of atherosclerosis—and the mechanisms by which toxins impair blood vessel relaxation. In his most cited study (34 citations), Eginton demonstrated that ascorbic acid (vitamin C) can prevent the injury to endothelium-dependent arterial relaxation caused by cigarette smoke, highlighting oxidative stress as a central pathway. His subsequent work (6 citations) provided compelling evidence that this smoke-induced endothelial injury is not permanent; by removing the smoke exposure, the arteries’ ability to relax normally can be restored. These findings carry significant clinical implications, suggesting that smoking cessation can reverse early vascular damage and that antioxidant supplementation may offer protective benefits. Eginton’s research bridges basic vascular biology with practical public health insights, offering hope that even after smoke exposure, the endothelium retains a remarkable capacity for recovery.
Research Focus
Key Achievements
Top Papers
- 1
- 2